Quantitative high-performance liquid chromatography-based detection method for calphostin C, a naturally occurring perylenequinone with potent antileukemic activity

This publication has 23 references indexed in Scilit:

• Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies
  Cancer, 1998
• Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.
  Journal of Clinical Oncology, 1998
• Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
  Journal of Clinical Oncology, 1998
• Early response to therapy and outcome in childhood acute lymphoblastic leukemia
  Cancer, 1997
• Calphostin C induces tyrosine dephosphorylation/inactivation of protein kinase Fa/GSK-3α in a pathway independent of tumor promoter phorbol ester-mediated down-regulation of protein kinase C
  Journal of Cellular Biochemistry, 1996
• Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in and cells: reversal of drug resistance possibly via P-glycoprotein
  Cancer Letters, 1994
• Calphostin‐C stimulates epidermal growth factor receptor phosphorylation and internalization via light‐dependent mechanism
  Journal of Cellular Physiology, 1994
• Calphostin C, a specific protein kinase C inhibitor, activates human neutrophils: Effect on phospholipase A2 and aggregation
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
• Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
  Biochemical and Biophysical Research Communications, 1989
• Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities.
  The Journal of Antibiotics, 1989